AUA2026 featured a wide range of content that is now available to be viewed on-demand thanks to educational grant support.
Bladder Cancer
Focus on: Non-Muscle Invasive Bladder Cancer Update for the Urology Care Team (NMIBC)
This educational activity is supported by independent educational grants from:
- AstraZeneca
- ImmunityBio
- Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
- UroGen Pharma, Inc.
Focus on: Metastatic Urothelial Carcinoma (mUC)
This educational activity is supported by independent educational grants from:
- Merck & Co., Inc.
- Pfizer, Inc.
Focus on: Muscle Invasive Bladder Cancer (MIBC)
This educational activity is supported by independent educational grants from:
- Pfizer, Inc.
Satellite Symposium – Maximizing NMIBC Outcomes: Personalized, Risk-Adapted Approaches With Intravesical Therapy and Collaborative Care
Kidney Cancer
Satellite Symposium – Second Opinion: Optimal Management of Localized Renal Cell Carcinoma
Prostate Cancer
AUA2026 Spotlight: PARP-Inhibitor Combination Treatments for the Urologic Care Team
This educational activity is supported by independent educational grants from:
- AstraZeneca
- Merck & Co., Inc
- Pfizer, Inc.
Focus on: Biomarkers, MRI and PSMA PET Imaging in Prostate Cancer
This educational activity is supported by independent educational grants from:
- Blue Earth Diagnostics, Inc.
- Lantheus Medical Imaging
Focus on: ADT in the Modern Era-Balancing Cancer Control and Cardiovascular Safety
This educational activity is supported by independent educational grants from:
- Pfizer, Inc
- Sumitomo Pharma America, Inc.
Advanced Prostate Cancer in the News 2026: A Case-Based Multidisciplinary Update
This educational activity is supported by independent educational grants from:
- Astellas
- Lantheus Medical Imaging
- Novartis Pharmaceuticals Corporation
- Pfizer, Inc
Contemporary Management of Advanced Prostate Cancer: Guidelines and Beyond
This educational activity is supported by independent educational grants from:
- Astellas
- Lantheus Medical Imaging
- Novartis Pharmaceuticals Corporation
- Pfizer, Inc
Should I Order a PET Scan? Integrating Molecular Imaging into Urologic Oncology Clinical Practice: Current Approaches and Future Opportunities
This educational activity is supported by independent educational grants from:
- Astellas
- Lantheus Medical Imaging
- Novartis Pharmaceuticals Corporation
- Pfizer, Inc
Incorporating Genomic Testing, Advanced Imaging, and Artificial Intelligence for Prostate Cancer into Your Practice
This educational activity is supported by independent educational grants from:
- Astellas
- Lantheus Medical Imaging
- Novartis Pharmaceuticals Corporation
- Pfizer, Inc
Satellite Symposium – Next-Generation Treatment Pathways in Prostate Cancer: Practical Case-Driven Guidance to Individualize Care in Localized, mHSPC, and mCRPC Disease
Satellite Symposium – Second Opinion: Investigators Provide Perspectives on the Current and Future Management of Patients with Prostate Cancer
Overactive Bladder
Focus on: Overactive Bladder for Advanced Practice Providers
This educational activity is supported by an independent educational grant from:
- Sumitomo Pharma America, Inc.
Urinary Tract Infection
Satellite Symposium – Breaking Barriers in cUTI Care: Integrating Novel Oral Therapies and Transitions of Care into Modern UTI Management
Satellite Symposia
Satellite Symposium – Maximizing NMIBC Outcomes: Personalized, Risk-Adapted Approaches With Intravesical Therapy and Collaborative Care
Satellite Symposium – Second Opinion: Optimal Management of Localized Renal Cell Carcinoma
Satellite Symposium – Next-Generation Treatment Pathways in Prostate Cancer: Practical Case-Driven Guidance to Individualize Care in Localized, mHSPC, and mCRPC Disease
Satellite Symposium – Second Opinion: Investigators Provide Perspectives on the Current and Future Management of Patients with Prostate Cancer
Satellite Symposium – Breaking Barriers in cUTI Care: Integrating Novel Oral Therapies and Transitions of Care into Modern UTI Management